118 related articles for article (PubMed ID: 28426233)
21. Ectonucleotidase Inhibitory and Redox Activity of Imidazole-Based Organic Salts and Ionic Liquids.
Boldescu V; Sucman N; Hassan S; Iqbal J; Neamtu M; Lecka J; Sévigny J; Prodius D; Macaev F
ChemMedChem; 2018 Nov; 13(21):2297-2304. PubMed ID: 30192439
[TBL] [Abstract][Full Text] [Related]
22. Structural analysis of dihydrofolate reductases enables rationalization of antifolate binding affinities and suggests repurposing possibilities.
Bhosle A; Chandra N
FEBS J; 2016 Mar; 283(6):1139-67. PubMed ID: 26797763
[TBL] [Abstract][Full Text] [Related]
23. Thermodynamic and NMR analysis of inhibitor binding to dihydrofolate reductase.
Batruch I; Javasky E; Brown ED; Organ MG; Johnson PE
Bioorg Med Chem; 2010 Dec; 18(24):8485-92. PubMed ID: 21084197
[TBL] [Abstract][Full Text] [Related]
24. Asymmetric mutations in the tetrameric R67 dihydrofolate reductase reveal high tolerance to active-site substitutions.
Ebert MC; Morley KL; Volpato JP; Schmitzer AR; Pelletier JN
Protein Sci; 2015 Apr; 24(4):495-507. PubMed ID: 25401264
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of small molecular dual inhibitor of falcipain-2 and dihydrofolate reductase as antimalarial agent.
Huang H; Lu W; Li X; Cong X; Ma H; Liu X; Zhang Y; Che P; Ma R; Li H; Shen X; Jiang H; Huang J; Zhu J
Bioorg Med Chem Lett; 2012 Jan; 22(2):958-62. PubMed ID: 22192590
[TBL] [Abstract][Full Text] [Related]
26. The effect of salts on the activity and stability of Escherichia coli and Haloferax volcanii dihydrofolate reductases.
Wright DB; Banks DD; Lohman JR; Hilsenbeck JL; Gloss LM
J Mol Biol; 2002 Oct; 323(2):327-44. PubMed ID: 12381324
[TBL] [Abstract][Full Text] [Related]
27. Solvent effects on catalysis by Escherichia coli dihydrofolate reductase.
Loveridge EJ; Tey LH; Allemann RK
J Am Chem Soc; 2010 Jan; 132(3):1137-43. PubMed ID: 20047317
[TBL] [Abstract][Full Text] [Related]
28. Effect of imidazolium-based ionic liquids on the photosynthetic activity and growth rate of Selenastrum capricornutum.
Pham TP; Cho CW; Vijayaraghavan K; Min J; Yun YS
Environ Toxicol Chem; 2008 Jul; 27(7):1583-9. PubMed ID: 18269297
[TBL] [Abstract][Full Text] [Related]
29. Incorporating dynamics in E. coli dihydrofolate reductase enhances structure-based drug discovery.
Lerner MG; Bowman AL; Carlson HA
J Chem Inf Model; 2007; 47(6):2358-65. PubMed ID: 17877338
[TBL] [Abstract][Full Text] [Related]
30. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
31. Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase.
Srinivasan B; Tonddast-Navaei S; Skolnick J
Eur J Med Chem; 2015 Oct; 103():600-14. PubMed ID: 26414808
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel Mycobacterium tuberculosis dihydrofolate reductase inhibitors through rational drug design.
Akhter M
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S96. PubMed ID: 28043639
[TBL] [Abstract][Full Text] [Related]
33. Kinetic folding of Haloferax volcanii and Escherichia coli dihydrofolate reductases: haloadaptation by unfolded state destabilization at high ionic strength.
Gloss LM; Topping TB; Binder AK; Lohman JR
J Mol Biol; 2008 Mar; 376(5):1451-62. PubMed ID: 18207162
[TBL] [Abstract][Full Text] [Related]
34. Investigation of osmolyte effects on FolM: comparison with other dihydrofolate reductases.
Bhojane PP; Duff MR; Patel HC; Vogt ME; Howell EE
Biochemistry; 2014 Mar; 53(8):1330-41. PubMed ID: 24517487
[TBL] [Abstract][Full Text] [Related]
35. Mechanism-based design, synthesis and biological studies of N⁵-substituted tetrahydrofolate analogs as inhibitors of cobalamin-dependent methionine synthase and potential anticancer agents.
Zhang Z; Tian C; Zhou S; Wang W; Guo Y; Xia J; Liu Z; Wang B; Wang X; Golding BT; Griff RJ; Du Y; Liu J
Eur J Med Chem; 2012 Dec; 58():228-36. PubMed ID: 23124219
[TBL] [Abstract][Full Text] [Related]
36. Tales of Dihydrofolate Binding to R67 Dihydrofolate Reductase.
Duff MR; Chopra S; Strader MB; Agarwal PK; Howell EE
Biochemistry; 2016 Jan; 55(1):133-45. PubMed ID: 26637016
[TBL] [Abstract][Full Text] [Related]
37. Characterization and comparative studies of zebrafish and human recombinant dihydrofolate reductases--inhibition by folic acid and polyphenols.
Kao TT; Wang KC; Chang WN; Lin CY; Chen BH; Wu HL; Shi GY; Tsai JN; Fu TF
Drug Metab Dispos; 2008 Mar; 36(3):508-16. PubMed ID: 18056255
[TBL] [Abstract][Full Text] [Related]
38. Room temperature ionic liquids and their mixtures: potential pharmaceutical solvents.
Mizuuchi H; Jaitely V; Murdan S; Florence AT
Eur J Pharm Sci; 2008 Apr; 33(4-5):326-31. PubMed ID: 18291630
[TBL] [Abstract][Full Text] [Related]
39. High-resolution structure of a plasmid-encoded dihydrofolate reductase: pentagonal network of water molecules in the D2-symmetric active site.
Narayana N
Acta Crystallogr D Biol Crystallogr; 2006 Jul; 62(Pt 7):695-706. PubMed ID: 16790925
[TBL] [Abstract][Full Text] [Related]
40. Thermodynamics and solvent effects on substrate and cofactor binding in Escherichia coli chromosomal dihydrofolate reductase.
Grubbs J; Rahmanian S; DeLuca A; Padmashali C; Jackson M; Duff MR; Howell EE
Biochemistry; 2011 May; 50(18):3673-85. PubMed ID: 21462996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
